Home » Topics » Disease categories and therapies » Endocrine/metabolic

Endocrine/metabolic
RSS

Droxia approved by FDA for sickle cell anemia

March 6, 1998

Mechanism of insulinotropic action of BTS-67582 explored in B-cells

March 5, 1998

New agents for lowering blood glucose and plasma triglycerides

March 5, 1998

Antidiabetic agents in development at Boehringer Mannheim

March 4, 1998

University of Alabama describes delta-EKLFs for hemoglobinopathies

March 4, 1998

J&J to withdraw from pramlintide collaboration; exendin update

March 4, 1998

Phase I results reported for alpha-gal in Fabry's disease

March 4, 1998

Ongoing clinical trials of Topiglan confirm positive early results

March 3, 1998

Vitamin C protects blood vessels in diabetic patients

March 3, 1998

Takeda in negotiations with potential marketing partner for pioglitazone

March 2, 1998

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
New mechanism of action identified for QC-6352
BioWorld Science
QC-6352 is a small molecule developed to inhibit the histone demethylase 4 (KDM4) that has shown potent antitumoral activity and which has a derivative named...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...